ArticleParasite (Paris, France)2025
First epidemiological survey of Toxoplasma gondii in Galapagos sea lions (Zalophus wollebaeki).
Article in Parasite (Paris, France), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High prevalence ofFrontiers in veterinary science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Toxoplasma gondii is the protozoan parasite responsible for toxoplasmosis, a zoonosis that represents a health risk for mammals, including marine species. Felines are the only definitive hosts of this parasite, playing a critical role in the introduction and maintenance of the pathogen in a new environment. Recent data demonstrate the contamination by T. gondii of the terrestrial and seawater environment of the Galapagos archipelago, in the Pacific Ocean. Little is known about the exposure of Galapagos' threatened species to T. gondii, although introduced domestic cats in the archipelago are known to be seropositive for T. gondii. We documented for the first time exposure to T. gondii of Galapagos sea lions (Zalophus wollebaeki), an endemic and emblematic species of the archipelago. The modified agglutination test revealed the presence of antibodies against T. gondii in 61 of 77 plasma samples collected in 2016-2017 from 2- to 4-year-old wild sea lions live-handled in their breeding sites on the inhabited island of San Cristóbal. Antibodies were also detected in 4 of 19 serum samples (21%) from sea lions whose corpses were found in 2021 on the same island. In addition, T. gondii DNA was detected in a lung sample from one necropsied pup and a tissue cyst-like structure was found in another, suggesting infection. These results, together with the high prevalence of antibodies in 2 to 4-year-olds, indicate that Galapagos sea lions are frequently exposed to T. gondii and raise concerns that toxoplasmosis may pose a threat to this endemic species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.